Table 1 The timeline of the patient’s clinical presentations and paraclinical findings during both admissions and follow-up period
Date | Day | Clinical description | Eosinophilia | STE (GLS) (%) | Bull’s eye (W&W) | LVEF by 2DE (%) | CMR |
|---|---|---|---|---|---|---|---|
18.04.2019 (first admission) | 1 | Fever, dyspnea, hypotension | Significantly positive | − 4.1 | Reduced LS (all segments) | 9.0 | |
23.04.2019 | 3–5 | No more fever, less dyspnea | Getting better, None on the 5th day | − 8.4 | Present | 24.0 | Acute inflammation (severe LGE) |
27.04.2019 | 9 | Doing much better | Absent | − 12.1 | Present | 31.0 | |
07.05.2019 | 19 | Doing well | Absent | − 13.9 | Present | 38 | |
03.07.2019 | 76 | No symptoms | Absent | − 17.1 | Present | 48.0 | |
Treatment non-compliance leading to disease recurrence | |||||||
18.07.2019 (second admission) | 91 | Fever, dyspnea | Present but less than the first admission | − 10.4 | Reduced LS mainly in the base, mid and apical regions | 24.0 | |
25.07.2019 | 98 | Feeling much better | Absent | − 14.6 | Present | 39 | Subendocardial and epicardial edema |
19.09.2019 | 153 | Doing well | Absent | − 12.9 | Present | 38.0 | Small areas of residual inflammation and scar formation |
20.11.2019 | 216 | No symptoms | Absent | − 15.8 | Present | 48.0 | |
21.01.2020 | 278 | No symptoms | Absent | − 13.2 | Present | 42.0 | |
25.04.2020 | 373 | No symptoms | Absent | − 14.6 | Present | 45.0 | |